Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Carcinoma, Ovarian Epithelial × epacadostat × Clear all

Sponsor

Conditions

Parkinson Disease 4, Autosomal Dominant Lewy Body 8 Carcinoma, Non-Small-Cell Lung 8 Melanoma 7 Squamous Cell Carcinoma of Head and Neck 6 Ovarian Neoplasms 6 Lung Neoplasms 6 Head and Neck Neoplasms 5 Stomach Neoplasms 3 Lymphoma 3 Colorectal Neoplasms 3 Carcinoma, Transitional Cell 3 Carcinoma, Renal Cell 3 Triple Negative Breast Neoplasms 2 Small Cell Lung Carcinoma 2 Neoplasm Metastasis 2 Glioblastoma 2 Esophageal Neoplasms 2 Endometrial Neoplasms 2 Carcinoma, Hepatocellular 2 Uveal Melanoma 1 Uterine Cervical Neoplasms 1 Urinary Bladder Neoplasms 1 Thymus Neoplasms 1 Thymoma 1 Sarcoma 1 Prostatic Neoplasms 1 Pancreatic Neoplasms 1 Neoplasms 1 Myelodysplastic Syndromes 1 Microsatellite Instability 1

Interventions

Paclitaxel 21 Carboplatin 16 liposomal doxorubicin 12 Bevacizumab 8 Topotecan 7 Docetaxel 7 Cisplatin 7 pembrolizumab 6 rucaparib 5 mirvetuximab soravtansine 5 Gemcitabine 5 Cyclophosphamide 5 Taxes 4 Albumin-Bound Paclitaxel 4 sargramostim 3 ixabepilone 3 Cytoreduction Surgical Procedures 3 130-nm albumin-bound paclitaxel 3 taxane 2 talazoparib 2 pazopanib 2 fludarabine phosphate 2 fludarabine 2 denileukin diftitox 2 cediranib 2 catumaxomab 2 belinostat 2 avelumab 2 aflibercept 2 Surgical Procedures, Operative 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡